Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2014 Volume 8 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2014 Volume 8 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer‑cell activation

  • Authors:
    • Yakun Wu
    • Yunbing Wang
    • Min Li
    • Xiaoli Yang
    • Jianping Gong
    • Wei Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Hepatobiliary Surgery, Suining Central Hospital, Suining, Sichuan 629000, P.R. China, Department of Hepatobiliary Surgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, P.R. China
  • Pages: 1777-1782
    |
    Published online on: October 10, 2014
       https://doi.org/10.3892/etm.2014.2015
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate the mechanism by which gadolinium chloride (GdCl3) inhibits Kupffer cell (KC) activation and its ability to suppress acute rejection and induce tolerance following liver transplantation in rats. Rats were randomly divided into control, liver transplantation with GdCl3 pretreatment and liver transplantation with normal saline pretreatment groups. The survival rate, liver function, hepatic pathological histology, cytokine levels in the liver and bile, activity of nuclear factor κ‑light‑chain‑enhancer of activated B cells (NF‑κB) in KCs, and expression levels of membranous molecules on the KCs were observed. It was identified that the one‑month survival rate in the GdCl3 group was significantly higher compared with that in the saline group (P<0.05). The liver function in the GdCl3 group gradually recovered following transplantation surgery; however, it progressively deteriorated in the saline group. There were minor changes of hepatic pathological histology in the GdCl3 group, whereas changes typical of acute rejection occurred in the saline group. In the GdCl3 group, the levels of interferon γ and interleukin (IL)‑2 were significantly lower whereas the levels of IL‑10 were significantly higher compared with those in the control and saline groups (all P<0.01). The IL‑4 levels in the GdCl3 and control groups were similar. The activity of NF‑κB in the saline group was significantly higher compared with those in the control and GdCl3 groups (P<0.01). The expression levels of major histocompatibility complex‑II, cluster of differentiation (CD)80 and CD86 on the KC membranes in the GdCl3 group was significantly lower compared with those in the control group (P<0.05); however, these membranous proteins were highly expressed in the saline group. These data indicate that GdCl3 efficiently inhibits the immunological activity of KCs, suppresses acute rejection and induces tolerance following liver allograft transplantation in rats.

Introduction

Postoperative acute rejection (AR) in clinical liver transplantation is a major cause of early allograft dysfunction and acute function failure. A number of studies suggest that the inhibitory effect of gadolinium chloride (GdCl3) against Kupffer cell (KCs) activation shows potential as a protective intervention in rat models of in vivo hepatic reperfusion injury and isolated perfused livers (1–3). It has also been shown that treatment of liver ischemia-reperfusion injury with GdCl3 reduces the mortality rate, attenuates neutrophil infiltration and decreases myeloperoxidase activity, improves hepatic function, reduces platelet accumulation in cold perfused livers, and prevents apoptosis of sinusoidal endothelial cells (4). Reduced free radical formation, lipid peroxidation, and parenchymal necrosis following GdCl3 administration have also been reported (5). In addition, treatment with GdCl3 diminishes the production of reactive oxygen species and the liberation of inflammatory mediators and inhibits the expression of adhesion molecules (6).

Thus, the identification of a treatment that is able to specifically inhibit AR and induce immune tolerance is urgent and essential. The activation of donor KCs is closely correlated with the occurrence of AR with intense phagocytosis, high expression levels of membranous molecules, clearly demonstrated antigen presentation, and the secretion of numerous cytokines that participate in the immune reaction (7–9). Therefore, by blocking the immune activity of KCs, AR may effectively be prevented and inhibited following surgery. In the present study, GdCl3 was used to inhibit the immune function of KCs and the depressant function of this treatment on liver transplantation AR was investigated, with the aim of investigating the underlying mechanism and providing experimental evidence for the successful inhibition of postoperative AR in clinical liver transplantation.

Materials and methods

Experimental animals and treatment

Male Lewis (LEW) and Brown Norway (BN) rats (210–250 g), used as donors and recipients, respectively, were purchased from the animal research center of Chongqing Medical University (Chongqing, China). All the animals were housed in the animal care facility and received humane care in accordance with the National Institutes of Health guidelines for animal research and the legal requirements in China. The study was approved by the Ethics committee of the Second Affiliated Hospital of Chongqing Medical University (Chongqing, China). All the rats were randomly divided into three groups. The control group comprised BN rats (n=10) that underwent exploratory laparotomy. The GdCl3 group (liver transplantation with GdCl3 pretreatment group) used LEW (n=15) and BN rats (n=15) and 2 g/l GdCl3 solution (7 mg/kg of body weight; Sigma-Aldrich, St. Louis, MO, USA) was injected via the vena caudalis into the donor with two days of continuous administration. On the third day, the donor liver was transplanted to the recipient. The saline group (liver transplantation with normal saline pretreatment group) used LEW (n=15) and BN rats (n=15), and all the operative procedures were just as in the GdCl3 group, with the exception of using an identical volume of normal saline instead of GdCl3 solution.

Construction of models of liver transplantation

Orthotopic liver transplantations were performed from the LEW to BN rats using Kamada’s method with a few modifications (10). The infrahepatic vena cava and the portal vein were linked with cuffs. The suprahepatic vena cava was inosculated with suture. A stent tube of the common bile duct was inserted into the common bile duct and the opening of the stent tube was left outside the body and used for collecting bile.

Analysis of plasma liver function markers and histopathological changes

The recipients were humanely sacrificed for histological inspection seven days post-surgery. The liver tissues were fixed in 100 g/l neutral formalin solution, embedded in paraffin wax and the sections were stained with hematoxylin and eosin to assess the morphological changes. The blood of rats was obtained through the caudal vein. Plasma liver function markers, specifically, serum alanine aminotransferase (ALT), aspartate transaminase (AST) and total bilirubin (TB), were measured with an automatic biochemical meter (Beckman CX7; Beckman Coulter, Brea, CA, USA).

Reverse transcription polymerase chain reaction (RT-PCR) for cytokine mRNA analysis

RNA was extracted from the liver tissue with a TRIzol reagent kit (Life Technologies, Carlsbad, CA, USA). RT-PCR was performed using an RT-PCR kit (Roche, Los Angeles, CA, USA). The cDNA produced was used for the amplification of interferon (IFN)-γ, IL-2, IL-4, IL-10 and β-actin, respectively (primers were made by the Shanghai Biochemical Products Factory, Shanghai, China). Specific primer sequences of IL-10, IL-2, IL-4, IFN-γ and β-actin were as follows: IL-10, forward: 5′-CCA AGC TTA TCG GAA ATG-3′, and reverse: 5′-CAC TTG TAA ATC TTT CTT CGGG-3′; IL-2, forward: 5′-TAG TGG CTG TCG AGA AGC TGC3′, and reverse: 5′-GGC GTC TTT CAT AGA CAG G-3′; IL-4, forward: 5′-CAT GGT CCG AGA TGT GCA ACT GGC-3′, and reverse: 5′-CGG GCT CAG CAA CTC CAG C-3′; IFN-γ, forward: 5′-CCA CGA GGA ATT CTA CGC CCT GGGC-3′, and reverse: 5′-AAG CTT GGG GAA CAG GTA GG-3′; β-actin, forward: 5′-CAT TGT GAT GGA CTC CGG AG-3′, and reverse: 5′-CTG CCG GTC CAG TAG TATA-3′. The PCR conditions were 30 cycles of denaturation at 94°C for 60 sec, annealing at 58°C for 60 sec and extension at 72°C for 60 sec, and finally an extension at 72°C for 7 min. Agarose gel electrophoresis was used to separate the products of PCR. Ethidium bromide staining, a gelatin imaging system and figure analysis system (GelDoc 2000; Bio-Rad, Hercules, CA, USA) were also used for observing and semiquantitatively counting their relative quantities, expressed as relative optical density (ROD) with normalization to β-actin.

ELISA for analysis of cytokines in bile

On the seventh day after transplantation, bile was collected in order to measure the expression levels of IFN-γ and IL-4 with an ELISA reagent kit (Beijing Dingguo Changsheng Biotech Co. Ltd., Beijing, China), following the manufacturer’s instructions.

Isolation of KCs

KCs were isolated using collagenase digestion and differential centrifugation using Percoll. KCs were collected and cultured in plates with RPMI-1640 solution at 37°C in the presence of 5% CO2. Non-adherent cells were removed after 6 h by replacing the buffer. The KCs were regulated to a density of 1×106 cells/well. The purity and viability of the cells were >90 and >95%, respectively. Next, the morphological characteristics of the KCs were observed under a phase contrast microscope (BX51; Olympus, Tokyo, Japan).

Detection of nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) in KCs

For NF-κB activity analysis, KCs were harvested and lysed at 24 h after liver transplantation, and nuclear proteins were extracted using an Active Motif Nuclear Extract kit (Active Motif, Carlsbad, CA, USA). The relative activity of NF-κB was represented by the optical density value of colorimetric analysis. The DNA-binding activity of NF-κB was determined by ELISA using the TransAM® NF-κB p65 Family kit (Active Motif), according to the manufacturer’s instructions. In brief, nuclear extract was transferred into a 96-well plate coated with NF-κB p65 consensus oligonucleotides. Subsequently, the NF-κB p65 protein bound to the target sequence was detected by primary rabbit anti-rat p65 antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) and a goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology Inc.). Absorbance was quantified by spectrophotometry (DR 5000 spectrophotometer, Hach Company, Indiana, USA) at 595 nm as a relative measure of protein-bound NF-κB p65.

Membranous molecules on KCs

A monoclonal antibody against major histocompatibility complex (MHC)-II, cluster of differentiation (CD)80 or CD86 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) combined with fluorescein isothiocyanate was added to the liquid suspension of KCs that was acquired previously and the mixture was incubated for 30 min. A flow cytometer (FC500 MPL; Beckman Coulter) was used to assay the positive cells and the mean fluorescence intensity.

Data analysis

All data are expressed as the mean ± standard deviation. Statistical analyses were performed with SPSS software, version 9.0 (SPSS Inc., Chicago, IL, USA). Analysis of variance with Fisher’s protected least significant difference post hoc analysis and Student’s test was used to identify significant differences between the groups. P<0.05 was considered to indicate a statistically significant difference.

Results

Survival condition of postoperative rats

In the initial two days following surgery, all rats in the GdCl3 and saline groups survived, and no difference in the quality of life was identified. From the third day following surgery, differences appeared between the groups. Food intake and energy levels gradually recovered to pre-operative levels in the GdCl3 group; however, in the saline group, these representations deteriorated. From the seventh day following surgery, the difference became increasingly evident. All the rats in the GdCl3 group survived and their general condition recovered to nearly normal levels. However, in the saline group, the rats presented clear occurrence of ascites, jaundice and even mortality. After the first month following surgery, the survival rates in the GdCl3 and saline groups were 86 and 47%, respectively, and the difference was statistically significant (P<0.01; Table I).

Table I

Survival rates of postoperative rats in the control, GdCl3 and saline groups.

Table I

Survival rates of postoperative rats in the control, GdCl3 and saline groups.

Postoperative survival rates, %

Group1 day2 days3 days4 days5 days7 days1 month
Control10010010010010010099
GdCl310010010010010010086a
Saline1001009387878047

a P<0.01 vs. saline group.

Histopathological changes of liver

Under a light microscope, the hepatocytes in the GdCl3 group presented moderate vacuolar degeneration and edema and a small number of inflammatory cells were observed to be infiltrating the portal area. However, in the saline group, the hepatocytes presented severe edema and large-area necrosis and large quantities of infiltrating inflammatory cells (not shown).

Plasma liver function markers

In the GdCl3 group, on the first day following surgery, the ALT, AST and TB levels were clearly elevated and the volume of bile secreted was decreased compared with those in the control group (P<0.05). Notably, from the second day after surgery, the aforementioned markers gradually recovered and by the fifth day after surgery, the markers were restored to normal levels. However, in the saline group, the aforementioned liver function markers were progressively aggravated, increasing to maximum levels on the seventh day following surgery (Fig. 1).

Figure 1

Plasma liver function markers level in the control, GdCl3 and saline groups at 1, 5 and 7 days after surgery. (A) ALT, (B) AST and (C) TB levels in the serum. (D) Secretion of bile in the three groups. *P<0.01 vs. control group;**P<0.01 vs. control and GdCl3 groups. ALT, alanine aminotransferase; AST, aspartate transaminase; TB, total bilirubin.

RT-PCR assay of hepatocellular cytokines

The expression levels of IFN-γ and IL-2 mRNA in the GdCl3 group were evidently lower compared with those in the control group (P<0.05); however, the IL-10 level in the GdCl3 group was higher than that in the control group (P<0.05) and the IL-4 levels showed no differences between the GdCl3 and control groups. The results for the saline group displayed an opposite trend to those in the GdCl3 group (Fig. 2).

Figure 2

mRNA expression levels of hepatocellular cytokines in the control, GdCl3 and saline groups. *P<0.05 vs. control group; **P<0.01 vs. control and GdCl3 groups. ROD, relative optical density; IFN, interferon; IL, interleukin.

ELISA analytical results of cytokines in bile

In terms of the ELISA analysis of bile, the concentration of IFN-γ in the GdCl3 group was markedly lower compared with that in the control group (P<0.05). However, the IL-4 level in the GdCl3 group increased compared with that in the control group (P<0.05). The changes observed in the saline groups were completely opposite to those in the GdCl3 group (Fig. 3).

Figure 3

ELISA analytical results of cytokines in the bile. *P<0.05 vs. control group; **P<0.01 vs. the respective control and GdCl3 groups. IFN, interferon; IL, interleukin.

NF-κB activity

The activity of NF-κB was not revealed to differ between the GdCl3 (1.25±0.63) and control (0.91±0.62) groups. However, NF-κB demonstrated an increased activity level in the saline (3.21±0.65) group compared with those in the control and GdCl3 groups (P<0.01; Fig. 4).

Figure 4

Relative activity of NF-κB represented by the optical density (OD) value in the control, GdCl3 and saline groups. **P<0.01 vs. control and GdCl3 groups. NF-κB; nuclear factor κ-light-chain-enhancer of activated B cells.

Expression levels of membranous molecules on KCs

The expression levels of MHC-II, CD80 and CD86 in the GdCl3 group were revealed to be lower compared with those in the control and saline groups (P<0.05). Additionally, the saline group highly expressed these three molecules (P<0.01; Fig. 5).

Figure 5

Expression levels of MHC-II, CD80 and CD86 in the control, GdCl3 and saline groups. *P<0.05 vs. control group; **P<0.01 vs. respective control and GdCl3 groups. MHC-II, major histocompatibility complex class II; CD, cluster of differentiation.

Discussion

KCs, which are the resident macrophages of the liver, not only exert phagocytosis but also excrete significant amounts of pro-inflammatory and anti-inflammatory cytokines. The understanding of the contribution of KCs to the inflammatory response is likely to help in developing immunological and pharmacological strategies aimed at attenuating the excessive cytokine secretion and decreasing immune damage. Although the role of KCs in directly inducing liver transplantation (LT) tolerance has been reported (7,11), immune tolerance by inhibition of KCs has been highlighted in numerous recent studies (11–13). A number of scholars in China and around the world have demonstrated that GdCl3 selectively reduces the number of KCs and their functions in experiments, through an unclear mechanism (3,4,14). Based on this point, if GdCl3 was used in a KC-associated study, the results may be beneficial in explaining the mechanism of hepatic postoperative acute rejection. In the present study, the aim was to explore the mechanism of the function of GdCl3 with regard to KCs and LT rejection and tolerance, and the following was concluded.

The KCs in the GdCl3 group represented a non-activated state with decreased apophysis on the cell surface, lower function of the organelle, and decreased expression of the MHC-II molecule. These observations indicate that GdCl3 treatment may inhibit or obstruct phagocytosis, absorption, antigen presentation and the combination capacity of the MHC of KCs with antigens or extraneous materials. In this way, immune rejection may be effectively prevented.

Activated T cells are critical in the immune response, and their activation requires two types of signal stimulus (from the combination of the T-cell receptor and the peptide-MHC and from co-stimulated molecules) (15). As identified in the GdCl3 group, the expression levels of co-stimulated molecules (CD80 and CD86) on the KCs decreased. A possible mechanism may be that by downregulating the expression of co-stimulated molecules on KCs, the activation of T lymphocytes at the upper stream was prohibited.

The activation of NF-κB plays a controversial role due to its dual action in the induction of both protective and pro-inflammatory genes. However, it is generally recognized that this dichotomy of NF-κB promoting the hepatic inflammatory response and also protecting against it reflects the expression of NF-κB-dependent genes in different hepatic cell populations (16). In the present study, it was identified that the activation of NF-κB in the group pretreated with GdCl3 was lower compared with that in the saline group. Thus, inhibiting the NF-κB activity in KCs may be considered as a route of inducing immune tolerance.

Th0 is able to differentiate into two subsets of helper T cells (Th1 and Th2), depending on the cytokine stimulation and production. Furthermore, the role of KCs in this process cannot be ignored. It is well known that cytokines produced by these two subsets play pivotal roles in the modulation of the immune response. As reported in numerous studies, the Th1 cytokines, including IFN-γ and IL-2, participate in the promotion of graft rejection (16–18). By contrast, an increased expression of the Th2 cytokines, including IL-10 and IL-4, may play a significant role in inducing an immune tolerance (19–24). This study also demonstrated that the IL-10 and IL-4 levels in the group pretreated with GdCl3 were evidently higher compared with the respective levels in the saline group; however, the IFN-γ and IL-2 levels in the GdCl3 group were clearly lower compared with those in the saline group. These results may indicate that deviation from Th1 to Th2 may be a mechanism of immune tolerance.

In conclusion, GdCl3 efficiently inhibited the immunological activity of KCs and suppressed acute rejection following liver allograft transplantation in rats. In addition, it may be concluded that the immune tolerance induced by the inhibitory effect of GdCl3 on KCs was a combined action requiring the participation of numerous mechanisms. In further studies, new cytokines and regulative routes could be identified to explain this effect, and further studies may also be necessary for understanding the exact mechanism.

Acknowledgements

The study was supported by the National Natural Science Foundation of China (grant no. 81370580).

References

1 

Rüttinger D, Vollmar B, Kempter B and Messmer K: Failure of Kupffer cell blockade to prevent disseminated intravascular coagulation in endotoxemic rats despite improved survival. Langenbecks Arch Surg. 383:75–80. 1998.PubMed/NCBI

2 

Vollmar B, Rüttinger D, Wanner GA, et al: Modulation of Kupffer cell activity by gadolinium chloride in endotoxemic rats. Shock. 6:434–441. 1996. View Article : Google Scholar : PubMed/NCBI

3 

Dimitrios G, George P, Stavros I, et al: The protective effect of alpha-tocopherol and GdCl3 against hepatic ischemia/reperfusion injury. Surg Today. 36:450–456. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Sindram D, Porte RJ, Hoffman MR, et al: Synergism between platelets and leukocytes in inducing endothelial cell apoptosis in the cold ischemic rat liver: a Kupffer cell-mediated injury. FASEB J. 15:1230–1232. 2001.PubMed/NCBI

5 

Giakoustidis DE, Iliadis S, Tsantilas D, et al: Blockade of Kupffer cells by gadolinium chloride reduces lipid peroxidation and protects liver from ischemia/reperfusion injury. Hepatogastroenterology. 50:1587–1592. 2003.PubMed/NCBI

6 

Jahnke C, Mehrabi A, Golling M, et al: Evaluation of microperfusion disturbances in the transplanted liver after Kupffer cell destruction using GdCl3: An experimental porcine study. Transplant Proc. 38:1588–1595. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Chen Y, Liu Z, Liang S, et al: Role of Kupffer cells in the induction of tolerance of orthotopic liver transplantation in rats. Liver Transpl. 14:823–836. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Chen Y, Liu H, Liu Z, et al: Blockade of inducible costimulator pathway to prevent acute rejection in rat liver transplantation. Am J Surg. 198:244–249. 2009. View Article : Google Scholar : PubMed/NCBI

9 

Xie X, Ye Y, Zhou L, et al: Küpffer cells promote acute rejection via induction of Th17 differentiation in rat liver allografts. Transplant Proc. 42:3784–3792. 2010.

10 

Delrivière L, Gibbs P, Kobayashi E, et al: Technical details for safer venous and biliary anastomoses for liver transplantation in the rat. Microsurgery. 18:12–18. 1998.PubMed/NCBI

11 

Chen GS and Qi HZ: Effect of Kupffer cells on immune tolerance in liver transplantation. Asian Pac J Trop Med. 5:970–972. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Tiegs G and Lohse AW: Immune tolerance: what is unique about the liver. J Autoimmun. 34:1–6. 2010. View Article : Google Scholar : PubMed/NCBI

13 

You Q, Cheng L, Kedl RM and Ju C: Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology. 48:978–990. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Jones C, Badger SA, Hoper M, et al: Hepatic cytokine response can be modulated using the Kupffer cell blocker gadolinium chloride in obstructive jaundice. Int J Surg. 11:46–51. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Lorenzo LP, Shatynski KE, Clark S, et al: Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome. Immunology. 139:447–458. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Llacuna L, Marí M, Lluis JM, et al: Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion. Am J Pathol. 174:1776–1785. 2009. View Article : Google Scholar

17 

Zhao X, Boenisch O, Yeung M, et al: Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am J Transplant. 12:90–101. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Zhao J, Li P and Gao S: Effect of TGF-beta1 on the expression of IL-12, IL-15, IL-18, IL-4 and IL-10 in heart transplantation rejection in rats. J Huazhong Univ Sci Technolog Med Sci. 27:643–645. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Chen Y, Yan T, Shi LJ, et al: Knockdown of interleukin-2 by shRNA-mediated RNA interference prolongs liver allograft survival. J Surg Res. 159:582–587. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Chen Y, Chen J, Liu Z, et al: Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats. Transplant Proc. 40:2691–2695. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Liao W, Zeng F, Kang K, et al: Lipoxin A4 attenuates acute rejection via shifting TH1/TH2 cytokine balance in rat liver transplantation. Transplant Proc. 45:2451–2454. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Feng JF, Chen F, Liu H, et al: Induction of immune tolerance by pre-infusion of apoptotic lymphocytes derived from peripheral blood of donor rats before liver transplantation. Minerva Chir. 68:183–189. 2013.PubMed/NCBI

23 

Hu A, Li Q, Shi H, et al: Donor-derived bone marrow transfusion produces mixed chimerism and promotes a Th2 shift in Th1/Th2 balance in rat heterotopic small bowel transplantation. Dig Liver Dis. 44:988–994. 2012. View Article : Google Scholar

24 

Lian ZR, Xu YF, Wang XB, et al: Suppression of histone deacetylase 11 promotes expression of IL-10 in Kupffer cells and induces tolerance following orthotopic liver transplantation in rats. J Surg Res. 174:359–368. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wu Y, Wang Y, Li M, Yang X, Gong J and Zhang W: Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer‑cell activation. Exp Ther Med 8: 1777-1782, 2014.
APA
Wu, Y., Wang, Y., Li, M., Yang, X., Gong, J., & Zhang, W. (2014). Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer‑cell activation. Experimental and Therapeutic Medicine, 8, 1777-1782. https://doi.org/10.3892/etm.2014.2015
MLA
Wu, Y., Wang, Y., Li, M., Yang, X., Gong, J., Zhang, W."Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer‑cell activation". Experimental and Therapeutic Medicine 8.6 (2014): 1777-1782.
Chicago
Wu, Y., Wang, Y., Li, M., Yang, X., Gong, J., Zhang, W."Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer‑cell activation". Experimental and Therapeutic Medicine 8, no. 6 (2014): 1777-1782. https://doi.org/10.3892/etm.2014.2015
Copy and paste a formatted citation
x
Spandidos Publications style
Wu Y, Wang Y, Li M, Yang X, Gong J and Zhang W: Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer‑cell activation. Exp Ther Med 8: 1777-1782, 2014.
APA
Wu, Y., Wang, Y., Li, M., Yang, X., Gong, J., & Zhang, W. (2014). Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer‑cell activation. Experimental and Therapeutic Medicine, 8, 1777-1782. https://doi.org/10.3892/etm.2014.2015
MLA
Wu, Y., Wang, Y., Li, M., Yang, X., Gong, J., Zhang, W."Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer‑cell activation". Experimental and Therapeutic Medicine 8.6 (2014): 1777-1782.
Chicago
Wu, Y., Wang, Y., Li, M., Yang, X., Gong, J., Zhang, W."Gadolinium chloride suppresses acute rejection and induces tolerance following rat liver transplantation by inhibiting Kupffer‑cell activation". Experimental and Therapeutic Medicine 8, no. 6 (2014): 1777-1782. https://doi.org/10.3892/etm.2014.2015
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team